Connect your AI

Evommune EVMN Line of Credit Remaining Borrowing Capacity

Line of Credit Remaining Borrowing Capacity at other companies

Moelis & CompanyMC

$4.37M-1.8%

Goldman Sachs BDCGSBD

$974.27M+35.3%

OGS

ONE GASOGS

$1.5B+11.2%

Blue Owl CapitalOWL

$1.08B+9.6%

State StreetSTT

$35.59B+4.3%

InsperityNSP

$380M+35.7%

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+42.8%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's line of credit remaining borrowing capacity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's line of credit remaining borrowing capacity?: Evommune (EVMN) reported line of credit remaining borrowing capacity of $450K in Q1 2026.